首页> 外文期刊>Infection and immunity >Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant.
【24h】

Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant.

机译:修饰的核糖肌苷-聚核糖酸,一种免疫佐剂。

获取原文
           

摘要

Stabilization of polyriboinosinic-polyribocytidylic acid against enzymatic hydrolysis by addition of poly-1-lysine and carboxymethylcellulose (PICLC) resulted in a compound with marked adjuvanticity. The primary antibody response of rhesus monkeys to formalin-inactivated Venezuelan equine encephalomyelitis virus vaccine was significantly potentiated if the vaccine was combined with PICLC prior to vaccination. The antibody response was maintained at a significantly higher level than controls for 2.5 months postvaccination and paralleled immunological responses reported for live, attenuated (TC-83) vaccine.
机译:通过添加聚-1-赖氨酸和羧甲基纤维素(PICLC)来稳定多核糖苷酸-多核糖酸对酶水解的稳定性,从而得到具有明显佐剂性的化合物。如果在接种疫苗前将疫苗与PICLC组合,则恒河猴对福尔马林灭活的委内瑞拉马脑脊髓炎病毒疫苗的一抗反应显着增强。疫苗接种后2.5个月,抗体应答维持在显着高于对照组的水平,并且报道了减毒活疫苗(TC-83)的平行免疫应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号